Atlas Trials

CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer

Clinical trial NCT07595835 · RECRUITING

Trial details

NCT number
NCT07595835
Sponsor
M.R. Meijerink
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2023-06-04
Primary completion
2026-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.